RespireRx Pharmaceuticals Inc (RSPI)

[All City Baby]

I'd say the stock is primarily where it's at because of the age of the company (I've been following this company for close to 30 years since when it was known as Cortex Pharmaceuticals). It's been around for so long that eventually the market just assumed it would fade into oblivion like most pennies, and over time the share price dwindled. To the credit of management they've been able to advance some of their drug candidates to a point where excitement has begun to build again.

I would say that its present sub-penny status is largely due to the dilution of the past year, their delinquency in terms of filing, and the company's lackluster (to put it rather kindly) marketing to the investment community. But I'm hopeful these issues can be turned around and the company becomes a more shareholder friendly company, which, in conjunction with sustained good news, could result in a highly impressive run that could manage to hold onto its gains (IMHO).